NeuroPace expects to use approximately $49.5 million of the net proceeds from the offering to repurchase 5,270,845 shares held by NeuroPace’s significant stockholder, KCK Ltd., at $9.40 per share, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback